Clinical Nursing Practice Supported by Results of Research: Mixed-method Study (PRACTICE)

November 29, 2024 updated by: Centro di Riferimento Oncologico - Aviano
The purpose of the study is to assess the attitudes and the use of research by nurses at the IRCCS-CRO Aviano. Furthermore, it will make it possible to identify attitudes towards the use/non-use of research results, specific training needs and targeted interventions to ensure adequate care for cancer patients along the disease course, derived from a constant updating of nursing skills. The study will involve nurses working in different care settings of the Institute and some patients who will be able to express their care needs and research priorities, making a direct contribution towards development of care centred on the health needs, preferences and values of the cancer patients.

Study Overview

Status

Recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

205

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Lucia Cadorin, PhD
  • Phone Number: 0434 659508
  • Email: lcadorin@cro.it

Study Locations

    • Pordenone
      • Aviano, Pordenone, Italy, 33081
        • Recruiting
        • Centro di Riferimento Oncologico (CRO) di Aviano - IRCCS
        • Contact:
        • Principal Investigator:
          • Lucia Cadorin, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Nurses employed at IRCCS-CRO Aviano and patients admitted to the institution as in-patients

Description

Inclusion criteria for nurses:

  • All nurses employed at IRCCS-CRO Aviano under fixed-term and permanent contract on 15 September 2023;
  • Nursing activities in the departments of medical and surgical oncology and high technologies;
  • Full-time and part-time employment contract;
  • Signature of consent for participation in the study and processing of personal data (Privacy).

Patient inclusion criteria:

  • Patients admitted to the institution as in-patients;
  • Age ≥ 18 years;
  • Signature of consent for participation in the study and processing of personal data (Privacy);
  • Good understanding of the Italian language.

Exclusion criteria for nurses:

- Lack of willingness/interest in participating in the study and signing the consent.

Patient exclusion criteria:

  • Day-Hospital patients;
  • Age < 18 years;
  • Diagnosis of cognitive dysfunction or psychiatric disorders;
  • Difficulties in understanding the Italian language.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Nurses employed at IRCCS-CRO Aviano
Patients admitted to the IRCCS-CRO Aviano as in-patients

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To assess the attitudes and use of research by nurses IRCCS of Aviano
Time Frame: 1 year
The Modified Research Utilization Questionnaire (M-RUQ), consisting of 22 items across three subscales assessed on a 5-point Likert scale (range: 22-110), will be used for data collection. Total scores are computed by summing and averaging domain scores, with reverse-scoring for negative items. Missing data will be imputed with item means, and results presented as mean ± standard deviation.
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To identify nursing issues, research priorities, and educational needs of nurses at IRCCS Aviano.
Time Frame: 1 year
he qualitative data obtained from the research (using interview and focus group method) will be evaluated with inductive content analysis, following Colaizzi's framework (1978). In order to enhance the validity of the data, two researchers will independently examine the transcripts, and comprehensive readings will be conducted. Codes will be generated and compared by interpreting differences and similarities, from which themes and sub-themes will be obtained
1 year
To explore care needs and research priorities of patients at IRCCS Aviano
Time Frame: 1 year
he qualitative data obtained from the research (using interview and focus group method) will be evaluated with inductive content analysis, following Colaizzi's framework (1978). In order to enhance the validity of the data, two researchers will independently examine the transcripts, and comprehensive readings will be conducted. Codes will be generated and compared by interpreting differences and similarities, from which themes and sub-themes will be obtained
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lucia Cadorin, PhD, Centro di Riferimento Oncologico (CRO) di Aviano - IRCCS

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 7, 2024

Primary Completion (Estimated)

March 7, 2025

Study Completion (Estimated)

March 7, 2025

Study Registration Dates

First Submitted

October 30, 2024

First Submitted That Met QC Criteria

October 30, 2024

First Posted (Actual)

October 31, 2024

Study Record Updates

Last Update Posted (Actual)

December 3, 2024

Last Update Submitted That Met QC Criteria

November 29, 2024

Last Verified

November 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CRO-2023-83

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Oncology

Subscribe